Text Size

MAVRIC VR ICD Registry

This study has been completed.
Sponsor:
Collaborator:
Medtronic
Information provided by:
Medtronic Cardiac Rhythm Disease Management
ClinicalTrials.gov Identifier:
NCT00270933
First received: December 28, 2005
Last updated: December 26, 2007
Last verified: December 2007
History of Changes
  Purpose

The purpose of this registry is to collect information on the health status of patients receiving Marquis/Maximo VR Implantable Cardiac Defibrillators (ICDs), how the devices are being programmed and how this correlates to clinical patient outcome.


Condition Intervention
Ventricular Tachycardia
Ventricular Fibrillation
 Device: Registry

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Marquis/Maximo VR ICD Programming Practices Registry (MAVRIC VR ICD Registry)

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Medtronic Cardiac Rhythm Disease Management:

Estimated Enrollment: 742
Study Start Date: January 2004
Estimated Study Completion Date: December 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients 18 years of age or older
  • Patients implanted with a new or replacement Marquis VR or Maximo VR ICD

Exclusion Criteria:

  • Patients enrolled in a device study that affects treatment and/or programming
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00270933

  Show 91 Study Locations
Sponsors and Collaborators
Medtronic Cardiac Rhythm Disease Management
Medtronic
Investigators
Principal Investigator: George Klein, M.D. London H.S.C. University Campus
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00270933     History of Changes
Other Study ID Numbers: 232
Study First Received: December 28, 2005
Last Updated: December 26, 2007
Health Authority: Canada: Ethics Review Committee
United States: Institutional Review Board

Keywords provided by Medtronic Cardiac Rhythm Disease Management:
defibrillators
LLECG
ventricular tachycardia
ventricular fibrillation

Additional relevant MeSH terms:
Tachycardia
Ventricular Fibrillation
Tachycardia, Ventricular
Arrhythmias, Cardiac
 Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 23, 2013